JP Morgan Chase
PCRX icon

JP Morgan Chase’s Pacira BioSciences PCRX Stock Holding History

JP Morgan Chase’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-75,000
Closed -$3.94M – 5689
2020
Q2 		$3.94M Buy
+75,000
New +$3.13M ﹤0.01% 2637
2018
Q4 		– Sell
-13,500
Closed -$664K – 5865
2018
Q3 		$664K Sell
13,500
-176,500
-93% -$7.63M ﹤0.01% 4139
2018
Q2 		$6.09M Buy
+190,000
New +$6.56M ﹤0.01% 2528
2017
Q3 		– Sell
-100,000
Closed -$4.77M – 5121
2017
Q2 		$4.77M Buy
+100,000
New +$4.64M ﹤0.01% 2504

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase's PCRX Position: Q1 2026 in Review

JP Morgan Chase reduced its Pacira BioSciences (PCRX) stake by 17% in Q1 2026, selling an estimated $1.07M and leaving 240,369 shares worth $5.59M. The position accounts for ﹤0.01% of the portfolio, ranked #3222.

JP Morgan Chase first reported a position in PCRX in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.9M in Q2 2014. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • JP Morgan Chase held 240,369 shares of Pacira BioSciences worth $5.59M as of Q1 2026.
  • JP Morgan Chase sold 48,282 Pacira BioSciences shares in Q1 2026, an estimated $1.07M.
  • Pacira BioSciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3222 holding.
  • JP Morgan Chase first reported a position in Pacira BioSciences in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Pacira BioSciences position peaked at $31.9M in Q2 2014.
  • 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.